Rifaximin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Rifaximin
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Rifaximin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 21 USDMF, 10 CEP/COS, 3 JDMF, 10 EU WC, 6 KDMF, 14 NDC API, 24 Listed Suppliers, $ API Reference Price

42 API Suppliers
21 USDMF
10 CEP/COS
3 JDMF
10 EU WC
6 KDMF
14 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 5 FDA Orange Book, 10 Europe, 1 Canada, 1 Australia, 1 South Africa, 17 Listed Dossiers

35 FDF Dossiers
5 FDA Orange Book
10 Europe
1 Canada
1 Australia
1 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 550MG

TABLET;ORAL - 200MG
TABLET;ORAL - 550MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

1 SPI Pharma
3 DKSH
7 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
1 Aeon Procare
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
2 BASF
10 Corel Pharma Chem
3 DFE Pharma
1 Finar
7 Gangwal Chemicals
7 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
17 Kerry
3 Kima Chemical
6 Lonza Capsugel
3 Microlex e.U
2 Novo Excipients
2 Pharmatrans-Sanaq
2 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
11 Roquette
6 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
2 The Dow Chemical Company
1 Valens Pharmachem
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives, 24 Controlled & Modified Release, 19 Fillers, Diluents & Binders, 16 Disintegrants & Superdisintegrants, 15 Direct Compression, 13 Thickeners and Stabilizers, 9 Film Formers & Plasticizers, 8 Granulation, 8 Co-Processed Excipients, 6 Lubricants & Glidants, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 4 Emulsifying Agents, 4 Topical, 3 Solubilizers, 3 Chewable & Orodispersible Aids, 2 Rheology Modifiers, 2 Parenteral

49 Coating Systems & Additives
24 Controlled & Modified Release
19 Fillers, Diluents & Binders
16 Disintegrants & Superdisintegrants
15 Direct Compression
13 Thickeners and Stabilizers
9 Film Formers & Plasticizers
8 Granulation
8 Co-Processed Excipients
6 Lubricants & Glidants
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Taste Masking
4 Coloring Agents
4 Emulsifying Agents
4 Topical
3 Solubilizers
3 Chewable & Orodispersible Aids
2 Rheology Modifiers
2 Parenteral

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 68 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
68 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Finished Drug Prices, 3 Annual Reports

1 US Medicaid Prescriptions
6 Finished Drug Prices
3 Annual Reports

MARKET PLACE

30 APIs, 7 FDF Dossiers

30 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

54 US Patents, 2 Health Canada Patents

54 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM

2 EDQM

$ API Ref.Price (USD/KG) : 234 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Bausch Health Companies Inc.

filter Patent Reset all filters

2 All

01 12538546

02 12594789

filter Product Reset all filters

2 All

01 2Rifaximin

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 12024-11-04

02 12026-02-27

Product Main Page

01

Bausch Health Companies Inc.

Rifaximin

Pharma, Lab & Chemical Expo

Not Confirmed

Bausch Health Companies Inc.

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-11-04

Date Granted : 2011-04-19

Brand Name : ZAXINE

Patent Number : 2538546

Filing Date : 2004-11-04

Strength per Unit : 550 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-11-04

Date Granted : 2011-04-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bausch Health Companies Inc.

Rifaximin

Pharma, Lab & Chemical Expo

Not Confirmed

Bausch Health Companies Inc.

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-27

Date Granted : 2010-09-14

Brand Name : ZAXINE

Patent Number : 2594789

Filing Date : 2006-02-27

Strength per Unit : 550 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-02-27

Date Granted : 2010-09-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?